Newsletter | August 22, 2024

08.22.24 -- Managing Risk In New And Emerging Trial Technology Trends

FEATURED EDITORIAL

Managing Risk In New And Emerging Trial Technology Trends

As technology advances, the risk that comes with integrating them into clinical trials rises. Beazley U.S. Life Sciences Underwriter Brendan Tarte discusses how to manage risk with tech like wearables, DHTs, AI/ML, and more.

INDUSTRY INSIGHTS

Acquiring Data From The Source: The Future Of EHR-To-EDC Technology

Learn about the benefits of employing EHR-to-EDC technology in the areas of clinical research, clinical trials, and data management in this Q&A with Mariel Boyd, Senior Product Manager at Flatiron Health.

Clinical Data Like You've Never Seen It Before: A Leading Analytics Platform

In a recent webinar, experts from Revvity Signals Software explored how solutions like its Spotfire platform enable better, more streamlined clinical studies.

Rethinking Today's ePRO Delivery For Tomorrow's Clinical Trials

Willie Muehlhausen, Co-CEO and Founder of Safira Clinical Research, and Tim Davis, VP of Strategy at MyVeeva for Patients, discuss how ePRO delivery needs to change to better serve modern trials.

eCOA Licensing Guide

In this comprehensive guide, IQVIA's eCOA library and licensing specialists, Kayla Doyle and Piero Bindi, explore five essential steps for obtaining licenses for the assessments required in your clinical trial.

Wearables In Clinical Trials: Real Benefits Beyond The Hype

Gain insight into the slow adoption rates and consider several compelling reasons why researchers should integrate these devices sooner rather than later.

Solving The EHR-To-EDC Challenge: A Scalable-First Approach

Unearth how industry shifts, technology adoption, and interoperability openness are paving the way for scalable solutions.

Modern Decentralized Trials Demand Advanced eClinical Support

First-generation eClinical systems can create as many challenges as they resolve. A more coherent solution is necessary to ensure data integrity, ease site burdens, and promote greater patient-centricity.